Comments
Loading...

Cardlytics Analyst Ratings

CDLXNASDAQ
Logo brought to you by Benzinga Data
$1.99
At close: May 15 EDT
$1.91
-0.08-4.00%
Pre-Market: 4:12 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$2.50
Consensus Price Target1
$6.13

Cardlytics Analyst Ratings and Price Targets | NASDAQ:CDLX | Benzinga

Cardlytics Inc has a consensus price target of $6.13 based on the ratings of 10 analysts. The high is $12 issued by Craig-Hallum on May 9, 2024. The low is $2.5 issued by Lake Street on May 8, 2025. The 3 most-recent analyst ratings were released by Lake Street, Lake Street, and Evercore ISI Group on May 8, 2025, March 13, 2025, and March 13, 2025, respectively. With an average price target of $2.83 between Lake Street, Lake Street, and Evercore ISI Group, there's an implied 48.31% upside for Cardlytics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jan
0
0
0
0
Mar
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.1
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Lake Street
Evercore ISI Group
Northland Capital Markets
B of A Securities
Craig-Hallum

1calculated from analyst ratings

Analyst Ratings for Cardlytics

Buy NowGet Alert
05/08/2025Buy Now30.86%Lake Street
Jacob Stephan64%
$3 → $2.5MaintainsHoldGet Alert
03/13/2025Buy Now57.04%Lake Street
Jacob Stephan64%
$5 → $3MaintainsHoldGet Alert
03/13/2025Buy Now57.04%Evercore ISI Group
Mark Mahaney82%
$4 → $3MaintainsIn-LineGet Alert
03/13/2025Buy Now—Needham
Kyle Peterson61%
—ReiteratesHold → HoldGet Alert
01/17/2025Buy Now—Needham
Kyle Peterson61%
—ReiteratesHold → HoldGet Alert
11/07/2024Buy Now—Needham
Kyle Peterson61%
—Reiterates → HoldGet Alert
10/11/2024Buy Now109.38%Evercore ISI Group
Mark Mahaney82%
→ $4Initiates → In-LineGet Alert
08/16/2024Buy Now161.73%Northland Capital Markets
Luke Horton13%
$7 → $5DowngradeOutperform → Market PerformGet Alert
08/15/2024Buy Now83.21%B of A Securities
Omar Dessouky64%
$4 → $3.5DowngradeNeutral → UnderperformGet Alert
08/08/2024Buy Now266.42%Northland Capital Markets
Luke Horton13%
$14 → $7MaintainsOutperformGet Alert
08/08/2024Buy Now—Needham
Kyle Peterson61%
—DowngradeBuy → HoldGet Alert
08/08/2024Buy Now161.73%Lake Street
Jacob Stephan64%
$18 → $5DowngradeBuy → HoldGet Alert
06/20/2024Buy Now475.8%B of A Securities
Omar Dessouky64%
→ $11Reinstates → NeutralGet Alert
06/18/2024Buy Now632.83%Northland Capital Markets
Luke Horton13%
→ $14Initiates → OutperformGet Alert
06/11/2024Buy Now528.14%Needham
Kyle Peterson61%
$12 → $12ReiteratesBuy → BuyGet Alert
05/09/2024Buy Now528.14%Craig-Hallum
Jason Kreyer59%
$18 → $12MaintainsBuyGet Alert
05/09/2024Buy Now528.14%Needham
Kyle Peterson61%
$17 → $12MaintainsBuyGet Alert
04/09/2024Buy Now789.87%Needham
Kyle Peterson61%
$15 → $17MaintainsBuyGet Alert
03/15/2024Buy Now842.21%Lake Street
Jacob Stephan64%
$13 → $18MaintainsBuyGet Alert
03/15/2024Buy Now842.21%Craig-Hallum
Jason Kreyer59%
$10 → $18UpgradeHold → BuyGet Alert
03/15/2024Buy Now685.18%Needham
Kyle Peterson61%
$12 → $15MaintainsBuyGet Alert
01/30/2024Buy Now528.14%Needham
Kyle Peterson61%
$12 → $12ReiteratesBuy → BuyGet Alert
11/29/2023Buy Now580.49%Lake Street
Jacob Stephan64%
→ $13Initiates → BuyGet Alert
11/09/2023Buy Now528.14%Needham
Kyle Peterson61%
$19 → $12MaintainsBuyGet Alert
08/02/2023Buy Now371.11%JP Morgan
Doug Anmuth86%
$6 → $9MaintainsNeutralGet Alert
08/02/2023Buy Now894.56%Needham
Kyle Peterson61%
$10 → $19MaintainsBuyGet Alert
06/06/2023Buy Now423.45%Needham
Kyle Peterson61%
→ $10ReiteratesBuy → BuyGet Alert
05/05/2023Buy Now423.45%Needham
Kyle Peterson61%
$8 → $10MaintainsBuyGet Alert
04/12/2023Buy Now214.07%Wells Fargo
Jeff Cantwell44%
$5 → $6MaintainsUnderweightGet Alert
04/05/2023Buy Now318.76%Needham
Mayank Tandon69%
→ $8Reiterates → BuyGet Alert
03/02/2023Buy Now214.07%JP Morgan
Doug Anmuth86%
$7 → $6MaintainsNeutralGet Alert
03/02/2023Buy Now161.73%Wells Fargo
Jeff Cantwell44%
$6 → $5MaintainsUnderweightGet Alert
03/02/2023Buy Now318.76%Needham
Kyle Peterson61%
$14 → $8MaintainsBuyGet Alert
01/09/2023Buy Now214.07%Wells Fargo
Jeff Cantwell44%
$10 → $6MaintainsUnderweightGet Alert
11/02/2022Buy Now423.45%Wells Fargo
Jeff Cantwell44%
$13 → $10MaintainsUnderweightGet Alert
11/02/2022Buy Now632.83%Needham
Kyle Peterson61%
$19 → $14MaintainsBuyGet Alert
09/08/2022Buy Now580.49%Wells Fargo
Jeff Cantwell44%
$14 → $13DowngradeEqual-Weight → UnderweightGet Alert
08/03/2022Buy Now632.83%Wells Fargo
Jeff Cantwell44%
$15 → $14MaintainsEqual-WeightGet Alert
08/03/2022Buy Now894.56%Needham
Kyle Peterson61%
$24 → $19MaintainsBuyGet Alert
07/14/2022Buy Now685.18%Wells Fargo
Jeff Cantwell44%
→ $15DowngradeOverweight → Equal-WeightGet Alert
07/13/2022Buy Now—B of A Securities
Nat Schindler68%
—DowngradeNeutral → UnderperformGet Alert
07/13/2022Buy Now1156.28%Needham
Kyle Peterson61%
$60 → $24MaintainsBuyGet Alert
07/12/2022Buy Now946.9%Craig-Hallum
Jason Kreyer59%
→ $20DowngradeBuy → HoldGet Alert
06/29/2022Buy Now1732.08%JP Morgan
Doug Anmuth86%
$47 → $35MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Cardlytics (CDLX) stock?

A

The latest price target for Cardlytics (NASDAQ:CDLX) was reported by Lake Street on May 8, 2025. The analyst firm set a price target for $2.50 expecting CDLX to rise to within 12 months (a possible 30.86% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cardlytics (CDLX)?

A

The latest analyst rating for Cardlytics (NASDAQ:CDLX) was provided by Lake Street, and Cardlytics maintained their hold rating.

Q

When was the last upgrade for Cardlytics (CDLX)?

A

The last upgrade for Cardlytics Inc happened on March 15, 2024 when Craig-Hallum raised their price target to $18. Craig-Hallum previously had a hold for Cardlytics Inc.

Q

When was the last downgrade for Cardlytics (CDLX)?

A

The last downgrade for Cardlytics Inc happened on August 16, 2024 when Northland Capital Markets changed their price target from $7 to $5 for Cardlytics Inc.

Q

When is the next analyst rating going to be posted or updated for Cardlytics (CDLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardlytics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardlytics was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.

Q

Is the Analyst Rating Cardlytics (CDLX) correct?

A

While ratings are subjective and will change, the latest Cardlytics (CDLX) rating was a maintained with a price target of $3.00 to $2.50. The current price Cardlytics (CDLX) is trading at is $1.91, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch